Finance

Lists
EQ:NASDAQ
Equillium Inc
$1.62
+0.31%
(+0.0050) 1D
$1.67
+2.77% (+0.045)
Pre-market
Closed: Sep 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EQ...
Open
$1.63
High
$1.66
Low
$1.58
Mkt. cap
103.04M
Avg. vol.
506.76K
Volume
262.00
52-wk high
$3.54
52-wk low
$0.76
EPS
-$0.20
Beta
1.81
Shares outstanding
63.41M
No. of employees
15
Open
$1.63
High
$1.66
Low
$1.58
Mkt. cap
103.04M
Avg. vol.
506.76K
Volume
262.00
52-wk high
$3.54
52-wk low
$0.76
EPS
-$0.20
Beta
1.81
Shares outstanding
63.41M
No. of employees
15
News stories
From web sources and news partners
About Equillium Inc
CEO-
Employees15
Founded2017
Headquarters-
SectorBiotechnology
Websiteequilliumbio.com
Analyst ratings
Based on 5 analysts giving stock ratings to EQ in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for EQ in the last 3 months.
Highest
Current $1.62
$20.00 (+1,130.77%)
Average
$11.60 (+613.85%)
Lowest
$7.00 (+330.77%)
Analyst
Recommendation
Action
Price target
Projected
Date
Adam Walsh
Roth MKM
Buy
Reiterated
$12.00
+638.5%
09/04/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$10.00
+515.4%
08/14/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$7.00
+330.8%
08/14/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
$9.00
+453.8%
08/03/2026
Yasmeen Rahimi
Piper Sandler
Buy
Initiated
$20.00
+1,130.8%
07/13/2026
William Wood
B. Riley Securities
Buy
Reiterated
$6.00
+269.2%
06/02/2026
Martin Auster
Raymond James
Buy
Maintained
$7.00
+330.8%
05/28/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Reiterated
$5.00
+207.7%
05/28/2026
Thomas Smith
Leerink Partners
Buy
Upgraded
$6.00
+269.2%
05/28/2026
David Siffringer
Cantor Fitzgerald
Buy
Initiated
$10.00
+515.4%
04/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.30M
1.54M
2.99M
2.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.27M
2.43M
2.62M
2.41M
Operating expense
4.58M
3.96M
5.61M
5.16M
Total operating expenses
4.58M
3.96M
5.61M
5.16M
Operating income
-4.58M
-3.96M
-5.61M
-5.16M
Other non operating income
-
-
-
-
EBT including unusual items
-4.23M
-3.78M
-5.31M
-4.69M
EBT excluding unusual items
-4.23M
-3.78M
-5.31M
-4.69M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.23M
-3.78M
-5.31M
-4.69M
Net profit margin
-
-
-
-
Earnings per share
-0.06
-0.04
-0.06
-0.04
Interest and investment income
235.00K
303.00K
309.00K
509.00K
Interest expense
-
-
-
-
Net interest expenses
235.00K
303.00K
309.00K
509.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.55M
-3.94M
-5.59M
-5.13M
Gain or loss from assets sale
-
19.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps